NeoGenomics’ PanTracer LBx Test Qualifies for Medicare Coverage Under MolDX Policy
The blood-based genomic profiling assay for advanced solid tumors is now reimbursable under Medicare’s policy covering plasma-based genomic profiling tests.
Read More
Search Results for: lung cancer
Hepion Pharmaceuticals Licenses ctRNA Biomarker Assay for Liver Cancer Detection
Hepion Pharmaceuticals has licensed a circulating tumor RNA assay from Cirna Diagnostics for early detection of hepatocellular carcinoma in high-risk patients, expanding its liquid biopsy portfolio for liver cancer.
Read More
Protein Biomarker Tests May Detect Cancer Earlier Than DNA-Based Methods
20/20 BioLabs argues a tiered screening approach—starting with protein-based tests before moving to circulating tumor DNA testing or imaging—could improve early-stage detection and lower costs.
Read More
Blood Test Predicts Survival in Older Adults
A Duke-led study reports that measuring piRNAs in blood samples predicts two-year survival in older adults with up to 86% accuracy, outperforming traditional health indicators, according to findings published in Aging Cell.
Read More
Deep Learning Pathology Models Caught ‘Cheating,’ Study Finds
A University of Warwick study finds AI cancer detection models may rely on statistical correlations rather than true biomarker signals, raising concerns about reliability in clinical pathology applications.
Read More